0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Cellular biology

Buy Now

Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 (Hardcover) Loot Price: R3,848
Discovery Miles 38 480
You Save: R375 (9%)
Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 (Hardcover): Joseph Landry, Swadesh Das, Paul B. Fisher

Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 (Hardcover)

Joseph Landry, Swadesh Das, Paul B. Fisher

Series: Advances in Cancer Research

 (sign in to rate)
Was R4,223 Loot Price R3,848 Discovery Miles 38 480 | Repayment Terms: R361 pm x 12* You Save R375 (9%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 of the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

General

Imprint: Academic Press Inc
Country of origin: United States
Series: Advances in Cancer Research
Release date: April 2023
First published: 2023
Volume editors: Joseph Landry • Swadesh Das • Paul B. Fisher
Dimensions: 229 x 152mm (L x W)
Format: Hardcover
Pages: 312
ISBN-13: 978-0-443-19418-4
Categories: Books > Science & Mathematics > Biology, life sciences > Cellular biology > General
Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Virology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General
Promotions
LSN: 0-443-19418-1
Barcode: 9780443194184

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners